Chronic Lymphocytic Leukemia With Lymphocytes of Unusual Immunologic Phenotype and Function
暂无分享,去创建一个
[1] R. Neiman,et al. T8 chronic lymphocytic leukemia. A distinctive disorder related to T8 lymphocytosis. , 1983, American journal of clinical pathology.
[2] R. Geha,et al. Immunoregulatory T-cell defects. , 1983, Immunology today.
[3] S. Hsu,et al. Lymphocyte subsets in normal human lymphoid tissues. , 1983, American journal of clinical pathology.
[4] R. Neiman,et al. Peripheral T-cell lymphoma: a clinicopathologic study of nine cases. , 1983, American journal of clinical pathology.
[5] J. Habeshaw,et al. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques. , 1983, British Journal of Cancer.
[6] R. Foà,et al. T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptors. , 1983, Clinical immunology and immunopathology.
[7] D. Catovsky,et al. T cell disorders in haematological diseases. , 1982, Clinics in haematology.
[8] J. Fujimoto,et al. Surface antigenic phenotypes of human T‐cell leukemia corresponding to those of post‐thymic T cells , 1982, American journal of hematology.
[9] G. de Rossi,et al. Immunologic evaluation of T chronic lymphocyte leukemia cells: correlations among phenotype, functional activities, and morphology. , 1982, Blood.
[10] N. Harris,et al. T-cell chronic lymphocytic leukemia. Report of a case studied with monoclonal antibody. , 1982, The American journal of medicine.
[11] N. Harris,et al. Chronic T-cell lymphocytosis with neutropenia: report of a case studied with monoclonal antibody. , 1981, Blood.
[12] G. Janossy,et al. Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies. , 1981, Clinical and experimental immunology.
[13] B. H. Davis,et al. Adenosine deaminase activity in lymphoid subpopulations and leukemias. , 1981, Cancer research.
[14] L. Chess,et al. Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population , 1981, The Journal of experimental medicine.
[15] J. Bach,et al. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. , 1981, Clinical and experimental immunology.
[16] G. Goldstein,et al. Cutaneous T cell lymphoma: characterization by monoclonal antibodies. , 1981, Blood.
[17] D. Knowles,et al. Cytochemically demonstrable B-glucuronidase activity in normal and neoplastic human lymphoid cells. , 1980, Blood.
[18] W. Selby,et al. Human T lymphocytes of inducer and suppressor type occupy different microenvironments , 1980, Nature.
[19] M. Husain,et al. T‐cell lymphomas of large cell type. A variety of malignant lymphomas: “Histiocytic” and mixed lymphocytic‐“histiocytic” , 1980, Cancer.
[20] F. Bollum. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. , 1979, Blood.
[21] A. Saxon,et al. T-cell leukemia in ataxia telangiectasia. , 1979, The New England journal of medicine.
[22] R. Foà,et al. Multiparameter studies in lymphoid leukemias. , 1979, American journal of clinical pathology.
[23] E. Reinherz,et al. Separation of functional subsets of human T cells by a monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Genel,et al. Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. , 1979, The New England journal of medicine.
[25] C. Li,et al. The cytochemistry of tartrate-resistant acid phosphatase. Technical considerations. , 1978, American journal of clinical pathology.
[26] A. Saxon,et al. T-lymphocyte variant of hairy-cell leukemia. , 1978, Annals of internal medicine.
[27] F. Siegal,et al. Surface markers in leukemias and lymphomas. , 1978, The American journal of pathology.
[28] J. Waldron,et al. Malignant lymphoma of peripheral T‐lymphocyte origin. Immunologic, pathologic, and clinical features in six patients , 1977, Cancer.
[29] J. Yodoi,et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.
[30] P. Lydyard,et al. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG , 1977, The Journal of experimental medicine.
[31] G. Flandrin,et al. CHRONIC LYMPHOCYTIC LEUKÆMIA OF T-CELL ORIGIN IMMUNOLOGICAL AND CLINICAL EVALUATION IN ELEVEN PATIENTS , 1975, The Lancet.
[32] A. Ahmed,et al. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. , 1975, Annals of internal medicine.
[33] D. Catovsky,et al. Prolymphocytic Leukaemia , 1974, British journal of haematology.
[34] D. Catovsky,et al. Prolymphocytic leukaemia of B and T cell type. , 1973, Lancet.
[35] C. Li,et al. ESTERASES IN HUMAN LEUKOCYTES , 1973, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[36] W. Crosby,et al. Cytochemical identification of monocytes and granulocytes. , 1971, American journal of clinical pathology.
[37] E. Reynolds. THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.
[38] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.
[39] D. Kiprov,et al. The effect of plasmapheresis and drug immunosuppression on T‐cell subsets as defined by monoclonal antibodies , 1983, Journal of clinical apheresis.
[40] K. Lennert,et al. MORPHOLOGY, CYTOCHEMISTRY, AND IMMUNOHISTOLOGY OF T CELL LYMPHOMAS , 1982 .
[41] R. Foà,et al. Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. , 1982, Leukemia research.
[42] M. Greaves,et al. Phenotypic heterogeneity and cellular origins of T cell malignancies. , 1981, Leukemia research.
[43] A. Böyum. Separation of leukocytes from blood and bone marrow. Introduction. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.